Cefdaloxime pentexil
Alternative Names: Cefdaloxime pentexil tosilate; HR 916; HR 916B; HR 916KLatest Information Update: 08 Jun 2001
At a glance
- Originator Aventis
- Class Antibacterials; Cephalosporins; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 08 Jun 2001 Discontinued-I for Bacterial infections in Japan (PO)
- 22 Dec 1999 Hoechst Marion Roussel has merged with Rhône-Poulenc Rorer to form Aventis Pharma